$Longeveron(LGVN)$ Announces Completion of Enrollment in Phase 2a Trial of Lomecel-B for the Treatment of Alzheimer’s Disease
CNS，退行性疾病
| 发布于: | Android | 转发：0 | 回复：0 | 喜欢：0 |
$Longeveron(LGVN)$ Announces Completion of Enrollment in Phase 2a Trial of Lomecel-B for the Treatment of Alzheimer’s Disease
CNS，退行性疾病